Correction to: Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Works matching IS 11750561 AND DT 2023 AND VI 24 AND IP 3
Results: 16
1
2
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 453, doi. 10.1007/s40257-023-00775-7
- By:
- Publication type:
- Article
3
Comment on: "Methotrexate Cutaneous Ulceration: A Systematic Review of Cases".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
4
Author's Reply to Parvathaneni et al. Comment on: "Methotrexate Cutaneous Ulceration: A Systematic Review of Cases".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
5
Comment on: "Eyebrow and Eyelash Alopecia: A Clinical Review".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
6
Blue Nail Discoloration: Literature Review and Diagnostic Algorithms.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 419, doi. 10.1007/s40257-023-00768-6
- By:
- Publication type:
- Article
7
Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA).
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 405, doi. 10.1007/s40257-023-00767-7
- By:
- Publication type:
- Article
8
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
9
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 443, doi. 10.1007/s40257-023-00764-w
- By:
- Publication type:
- Article
10
Efficacy and Safety of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: An Updated Systematic Review and Meta-analysis (2009–2022).
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 359, doi. 10.1007/s40257-023-00763-x
- By:
- Publication type:
- Article
11
Treatment of Recurrent Melanoma Following Adjuvant Therapy.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 333, doi. 10.1007/s40257-023-00762-y
- By:
- Publication type:
- Article
12
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don't Know.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 397, doi. 10.1007/s40257-023-00761-z
- By:
- Publication type:
- Article
13
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 381, doi. 10.1007/s40257-023-00759-7
- By:
- Publication type:
- Article
14
Muir–Torre Syndrome: A Cutaneous Finding Amidst Broader Malignancies.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 375, doi. 10.1007/s40257-023-00757-9
- By:
- Publication type:
- Article
15
Effects of Exercise and Dietary Modifications on Hidradenitis Suppurativa: A Systematic Review.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 343, doi. 10.1007/s40257-023-00756-w
- By:
- Publication type:
- Article
16
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 3, p. 469, doi. 10.1007/s40257-022-00754-4
- By:
- Publication type:
- Article